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Abstract
Background: UDP-glucose dehydrogenase (UGDH) is the sole enzyme that catalyzes the conversion of UDP-glucose to UDP-
glucuronic acid. The product is used in xenobiotic glucuronidation in hepatocytes and in the production of proteoglycans
that are involved in promoting normal cellular growth and migration. Overproduction of proteoglycans has been implicated
in the progression of certain epithelial cancers, while inhibition of UGDH diminished tumor angiogenesis in vivo. A better
understanding of the conformational changes occurring during the UGDH reaction cycle will pave the way for inhibitor
design and potential cancer therapeutics.
Methodology: Previously, the substrate-bound of UGDH was determined to be a symmetrical hexamer and this regular
symmetry is disrupted on binding the inhibitor, UDP-a-D-xylose. Here, we have solved an alternate crystal structure of
human UGDH (hUGDH) in complex with UDP-glucose at 2.8 A ˚ resolution. Surprisingly, the quaternary structure of this
substrate-bound protein complex consists of the open homohexamer that was previously observed for inhibitor-bound
hUGDH, indicating that this conformation is relevant for deciphering elements of the normal reaction cycle.
Conclusion: In all subunits of the present open structure, Thr131 has translocated into the active site occupying the volume
vacated by the absent active water and partially disordered NAD
+ molecule. This conformation suggests a mechanism by
which the enzyme may exchange NADH for NAD
+ and repolarize the catalytic water bound to Asp280 while protecting the
reaction intermediates. The structure also indicates how the subunits may communicate with each other through two
reaction state sensors in this highly cooperative enzyme.
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Introduction
UDP-glucose 6-dehydrogenase (UGDH; EC 1.1.1.22) is the sole
human enzyme that converts UDP-a-D-glucose (UDP-glucose) to
UDP-a-D-glucuronic acid (UDP-glucuronic acid), an intermediate
sugar in carbohydrate metabolism [1]. UDP-glucuronic acid is
incorporated into hyaluronan, chondroitin sulfate, heparan sulfate,
and glycosaminoglycans. C5 epimerization leads to iduronate for
inclusion in heparan sulfate and dermatan sulfate. Such extracel-
lular matrix carbohydrates promote normal cellular growth,
embryogenesis and adult organism physiology [2,3,4]. In addition,
UDP-glucuronic acid is used in the glucuronidation of many
molecules including drugs, nuclear hormones, retinoids, bile acids,
bilirubin, and fatty acid derivatives by UDP-glucuronosyl
transferase in hepatocytes [5]. UGDH is also implicated in tumor
progression and osteoarthritis [6,7,8]. Overproduction of proteo-
glycans has been observed in the progression of epithelial cancers
such as colon, breast, and prostate [9,10,11]. Inhibition of
hUGDH has been demonstrated to diminish tumor angiogenesis
in vivo [12], while UGDH gene disruption in zebrafish led to a
heart valve defect [13].
Bovine UGDH was first identified in the liver [14], later purified
[15] and the amino acid sequence determined [16]. Molecular
cloning of hUGDH revealed it to be a 494-amino acid protein that
shares 98% identity to bovine UGDH [17,18,19]. hUGDH is a
hexamer of 57-kDa subunits that assembles into a trimer of
dimers. UGDH is a member of a small group of NAD
+-dependent
four-electron-transfer dehydrogenases. Substrate, inhibitor and
product binding experiments and chemical modification studies all
point towards three subunits being catalytically active at any one
time, mirroring the structural assembly [1,20,21,22,23]. UGDH is
also found in prokaryotes, producing the UDP-glucuronic acid
that is essential for the synthesis of antiphagocytic capsular
polysaccharides [24,25,26]. The crystal structures of dimeric S.
pyogenes UGDH provided the structural basis for the reaction
cycle (Fig. 1A,C) [27], which was further refined through
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25226elucidation of hUGDH hexameric structures (Fig. 1B,C) [28].
UGDH catalyzes two NAD
+-dependent oxidations of UDP-
glucose, the first reversible, to yield UDP-glucuronic acid in an
overall irreversible process [29,30]. The structures of hUGDH in
complex with NAD
+ and UDP-glucose, a E161Q hUGDH
mutant bound to the thiohemiacetal intermediate, hUGDH in
complex with the product UDP-glucuronate and a T131A
hUGDH mutant in the apo form (PDB codes 2Q3E, 3KHU,
2QG4 and 3ITK, respectively) are all closed hexamers [28]. In
contrast, inhibitor-bound hUGDH adopts an open hexameric
conformation in which the three-fold symmetry has been broken
[31]. Here, we have solved an alternate substrate-bound structure
of hUGDH, which reveals the asymmetrical open hexameric
quaternary conformation that was previously observed in the
inhibitor-bound structure. Conformational differences between
open and closed hexamer conformations suggest structural-based
mechanisms for the repolarization of the active water molecule,
reaction intermediate protection, and cooperativity between
subunits.
Results
Structure of hUGDH
The structure of hUGDH in complex with NAD
+ fragments
and UDP-glucose was solved by molecular replacement and
refined against 2.8 A ˚ resolution data (Table S1) [32]. The crystal
asymmetric unit contains two open hexamers arranged as a closed
dodecamer (Fig. 2). We refer to the twelve hUGDH subunits as
subunits A to F and G to L, representing the two open hexamers of
the dodecamer within the crystal asymmetric unit, respectively.
Twelve-fold non-crystallographic restraints were maintained up to
the last cycle of refinement. The placement of residues, discussed
below, stand up to twelve-fold averaging of the electron density
maps providing a higher level of confidence in these features than
Figure 1. Mechanism of hUGDH catalysis. (A) In the first phase of the mechanism established from the structure of bacterial UGDH (Easley et al.,
2007), a water molecule, activated by Asp280, is predicted to be the general acid/base catalyst that abstracts a proton from the C69 hydroxyl to
initiate oxidation. Mutation of Asp280 to Asn is detrimental to catalysis. An aldehyde intermediate is transiently formed at the active site (Ia). This
aldehyde has not been detected experimentally [14], however, added aldehyde functions as a substrate for the second oxidation [45]. The
intermediate is then proposed to rapidly convert to the thiohemiacetal adduct (IIa), via Cys276, without being released and the second NAD
+ to
replace the first reduced cofactor, NADH. (B) In an updated mechanism (Ib and IIb), the reaction proceeds directly to the thiohemiacetal adduct
without proceeding through the aldehyde intermediate [28]. (C) In the second phase of both mechanisms, the thiohemiacetal is then oxidized to the
thioester via transfer of hydrogen to NAD
+ (III). Finally the acid product is released through spontaneous hydrolysis [46,47]. Here the water bound to
Asp280 is highlighted as the probable active water molecule. Evidence for a covalent thiohemiacetal (II) lies in the observation that the second
deprotonation step (III) is reversible while the overall conversion to acid is irreversible (V) [38]. Mutation of Cys276 to serine led to the build up of
covalently attached adduct, however, the C276A mutation, while not able to proceed to completion from UDP-glucose, was able to catalyze the
oxidation of the aldehyde intermediate [45]. Lys220 provides charge stabilization to the anionic transition state during the second oxidation step (III),
and for the course of the hydrolysis of the thioester (IV and V). Mutation of Lys220 significantly, but not completely, reduced the enzyme function
suggesting that it does not form a Schiff’s base [34,48]. Features in blue and red indicate that Thr131 and Asp280 coordinate the movements of
NAD
+/NADH and the active water molecule.
doi:10.1371/journal.pone.0025226.g001
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resolution data.
Three-domain protomer
The hUGDH protomer consists of three domains. The N- and
C-terminal domains are structurally homologous a/b structures,
comprising core b-sheets sandwiched between a-helices (Fig. 2A,
blue and red, respectively). These two domains sit upon an
extended a-helical central domain (Fig. 2A, green). The
topologies of the a/b domains are characteristic of the
dinucleotide-binding Rossmann fold (Fig. 3) [33]. The six-
stranded parallel b-sheet (b1–b6, residues 1–161) of the N-
terminal domain is followed by an additional b-a-b unit (b7, a8
and b8, residues 179–212). The b-strands of this unit are
antiparallel with respect to the Rossmann fold (Fig. 3B). The
NAD
+ fragments (Fig. 2A, yellow) are bound in the cleft between
strands b2a n db4 and lying across the b1-a1 loop. This would
position the nicotinamide portion, which is not visible in this
structure, at the substrate-binding site formed at the interface
between the three domains. The a/b C-terminal domain
(residues 329–466) consists of a six-stranded sheet (b19–b14)
packed with a-helices on both sides (Fig. 3B). This second
Rossmann fold is responsible for binding the UDP moiety of
UDP-glucose (Fig. 2A, purple), positioning the sugar moiety at
the active site. The central domain is comprised of four helices
(a9–a12, residues 213–323). The first and last of these helices are
extended and cross to form the scaffolding that positions the N-
and C-terminal domains, respectively.
Tightly associated dimeric unit
The protomers are arranged in pairs associated through
dimerization of the central domains in an interface of 2600 A ˚ 2
(Fig. 2B). Arg260 situated in a loop within the central domain of
one protomer reaches across to contact and position the glucose
from the UDP-glucose within the second protomer (Fig. 4). The
subsequent polypeptide chain, residues 265–280 that includes
active site residues Cys276 and Asp280 (Fig. 1), wraps around the
UDP-glucose from the first protomer forming multiple contacts.
Hence, the occupancy of the UDP-glucose binding site within
one half of the dimeric unit will be sensitive to that in the second
half, suggesting cooperativity within the dimeric unit [28].
Furthermore, the dimerization interface may provide a platform
Figure 2. Structure of hUGDH. (A) Schematic representation of a hUGDH protomer taken from the dodecamer. N-terminal, central and C-terminal
domains are colored blue, green and red, respectively. UDP glucose is shown in purple, NAD
+ in yellow. (B) The closely associated dimeric unit taken
from the dodecamer. The second copy of the central domain is tinted orange. (C) The dodecameric hUGDH arrangement that is present in the crystal
asymmetric unit comprised of two open hexamers. Upper panel shows the top layer of the dodecamer. Central and lower panels depict the full
dodecamer in space filled representation. The twisted conformation is evident from the lower panel. (D) For comparison, a typical symmetric hexamer
of hUGDH taken from PDB code 2Q3E. Movies S1 and S2 show morphs between these two structures. Protein representations were generated here,
and in the figures that follow, using PYMOL (http://pymol.sourceforge.net/).
doi:10.1371/journal.pone.0025226.g002
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flexing of the central domains. The overall fold of the hUGDH
protomer and the dimer interaction closely resemble that of the
obligate dimer of UGDH from S. pyogenes [27].
Open hexamer
Three copies of the hUGDH dimeric unit are arranged as a
hexamer, through interactions between helix and loop structures in
the N-terminal and C-terminal domains on neighboring protomers
Figure 3. Secondary structure and topology of the hUGDH protomer. (A) Secondary structure elements shown above the hUGDH amino
acid sequence in domain colors (N-terminal, blue; central, green; C-terminal, red). Important active site residues are boxed. (B) Topology of the
protomer. The figures were generated in ALSCRIPT [49] and TOPDRAW [50].
doi:10.1371/journal.pone.0025226.g003
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and a6-helix from the N-terminal domain interact with the a13–
b10 loop and a17–b13 loop that includes the a18-helix from C-
terminal domain of the next protomer, respectively, while both N-
terminal regions interact with the linkera12–b9 between thecentral
and C-terminal domains. The interface area is approximately
700 A ˚ 2 between any two protomers in these inter-dimer contacts.
An interaction from Asn292 to Asn292 links the central domains
between pairs of dimers (A–F, B–C, G–L and H–I). The amino acid
sequences at the inter-dimer contact regions show significant
variability in comparison to the S. pyogenes obligate dimer,
displaying three insertions, one deletion and different mainchain
structures. The present structure has opened up to form an
asymmetric hexamer (open hexamer) in comparison to the
symmetric hexamer [28], PDB code 2Q3E (closed hexamer)
(Fig. 2D). Despite these large differences in quaternary structure,
the protomer structures from the open and closed hexamers show
only small variations in conformation (RMSD of 0.83 A ˚, Table
S2A) and similar interdomain arrangements (Table S2E). This
compares with an RMSD of 0.18–0.43 A ˚ for protomers within the
openhUGDH hexamer.Superimpositionof theindividual domains
of closed and open hexamer protomers does not reveal a significant
conformational differenceinC-terminal domains(RMSD=0.41 A ˚,
Table S2D) or the central domains (RMSD=0.35 A ˚, Table S2C),
whereas a comparison between N-terminal domains showed a
slightly larger deviation (RMSD=0.93 A ˚, Table S2B). These data
indicate that the conformational difference detected from the whole
hUGDH mainly results from structural plasticity in the N-terminal,
NAD
+-binding domain. Comparison of the open and closed
hexamer protomers to reaction intermediate-bound and apo forms
of the hUGDH shows larger variation (Tables S2A–E). In these
structures, the separation of the N- and C-terminal domains slightly
varies through rotation on the central domain backbone. However,
the individual domains follow a similar pattern of relatedness to the
open hexamer protomer as was determined for the closed hexamer.
In contrast, the open hexamer structure determined here adopts the
conformation observed for UDP-a-D-xylose bound UGDH [31]
(RMSD=0.29–0.34 A ˚ between the protomers). Hence, this open
hexamer UGDH conformation can interact with both the substrate
and inhibitor.
Asymmetric unit dodecamer
The asymmetric unit, within the crystal, contains two open
hexamers arranged in a slightly twisted manner so that the open
edges of the two hexamers (Fig. 2C). The areas of interaction
surfaces are 220 A ˚ 2 (C:K and E:I) and 280 A ˚ 2 (D:L and F:J). Such
contact areas are in the range observed for crystal contacts rather
than for protein-protein interactions. Size exclusion analysis of
hUGDH by FPLC, dynamic light scattering, and electron
micrographs are consistent with the hexameric structure [34,35,
36]. However, sedimentation velocity experiments suggest that
apo-UGDH is a complex mixture of dimers, hexamers and small
amounts of monomers and tetramers [31]. Furthermore, a single
mutation (Lys339Ala) or double mutation (Ala222Gln and
Ser233Gly) in hUGDH converts the hexamer to a dimer
[34,37]. These residues do not lie at the inter-dimer interfaces.
Taken together, these data indicate that the hexameric structure is
not highly stable. Hence, we suggest that the open hexamer
conformation observed here results from the solution conditions
and state of the NAD
+ and is unlikely to be a major substrate-
bound conformation under physiological conditions, nonetheless it
provides valuable insight into the enzyme function.
NAD
+ binding
Detailed comparison of the NAD
+ conformations in this
structure and those previously reported for the closed hexamer
(2Q3E [28]) indicates striking differences. In the closed hexamer,
the structure of each NAD
+ molecule bound to every hUGDH
protomer is well defined. The NAD
+ molecules in the present open
hexamer structure are partially disordered (Fig. 5A and Figure
S1A). Similarly, disordered nicotinamide rings were found in the
inhibitor-bound and thiohemiacetal-bound structures [28,31]. The
partially disordered NAD
+ has direct consequences for protein
structure around the NAD
+-binding site. In comparison to the
closed hexamer, the open hexamer residues Ser130 and Thr131
have made a large switch toward the interior of the NAD
+-binding
site to occupy the space vacated by the disordered nicotinamide
moiety and the absent catalytic water (Fig. 5). These conforma-
tional differences with respect to the closed hexamer are observed
in all twelve protomers and are not dependent on position within
the open hexamer. This indicates that the conformational changes
are likely to be dependent on the occupation of the NAD
+ and
catalytic water binding sites rather than induced by the opening of
the hexamer. The Thr131 loop movement at the NAD
+-binding
site results in long-range conformational changes of the loop-a6
Figure 4. Cooperativity within the hUGDH dimeric unit. (A)
Residues 265–280 wrap around and orient UDP-glucose in one subunit
while Arg260 forms two hydrogen bonds to the glucose moiety of UDP-
glucose in the second protomer. Hence, residues 260–280, which
include active site residues Cys276 and Asp280, may act as a sensor by
transmitting the state of one UDP-glucose binding site to the other
protomer at the dimer interface. (B) Close up of the UDP-glucose
binding site.
doi:10.1371/journal.pone.0025226.g004
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domains of each protomer within the dodecamer (Fig. 5). This
region includes an intersubunit contact site in the trimer unit
(Fig. 2C). We speculate that, under the crystallization conditions,
NAD
+-binding site induced rearrangement of the b5-a6-b6 region
placed strain on the hexamer causing it to open.
UDP-glucose binding
The UDP-glucose is well defined in the active site (Fig. 6) and
the UDP portion is essentially identical in all 12 crystallographic
protomers. However, the oxygen of the C69 hydroxyl shows poor
density, and hence, its positioning was determined by the general
fitting of the glucose ring to the electron density (Figure S1B). The
glucose moiety appears to display a distribution of positions
ranging from one in which the C69 hydroxyl is within bonding
distance to Cys276 (as in subunit A, Fig. 6A) to an orientation
where the C69 hydroxyl is close to Lys220 (subunit L, Figure S1C).
Movement of residues Ser130 and Thr131 into the space occupied
by the missing NAD
+ nicotinamide ring has important conse-
quences for the active water molecule and active site residues.
Firstly, Asp280 coordinates the catalytic water in the closed
hexamer protomers (Figs. 1 and 6b). In the open hexamer
protomers there is no bound active water. Instead, Thr131
occupies the former location of the active water and causes Asp280
to turn away from the UDP-glucose (Fig. 6C,D and Figure S2).
Asp280 (atom OD2) lies within hydrogen-bonding distance (mean
distance 2.72 A ˚) of the mainchain carbonyl oxygen of Leu221,
indicating that the acid is protonated. The sulphur atom of the
catalytic Cys276 is also significantly displaced, relative to the open
hexamer protomers, and turns towards Asn224 (mean SG to ND2
distance 3.51 A ˚), suggesting that Cys276 is not protonated.
Discussion
Enzymes, particularly in higher organisms, display a tendency
to form large multimers. Cooperativity provides a possible
explanation for such refinement during evolution. Through linking
reaction cycles between subunits, and hence sharing energy, an
enzyme has the opportunity to alter energy barriers at points in the
reaction cycle that would not be available to an isolated protomer.
The present structure of hUGDH displays an asymmetric open
hexameric conformation. This open conformation was previously
observed for the non-productive inhibitor-bound hUGDH. Here,
we speculate that this distorted substrate-bound conformation is
unlikely to be that of a native conformation but rather one that has
been pushed to extreme through solution conditions and ligand
binding. Nevertheless, conformational differences between the
open form and the closed forms of hUGDH provide important
insights into the structural basis of cooperativity within the
hexamer.
UGDH displays a high degree of cooperativity between subunits
[1] operating as a ‘‘trimer of dimers’’ in which only three subunits
are simultaneously active. A structural indication of this trimer of
dimers is observed in the thiohemiacetal-trapped E161N hUGDH
mutant structure (PDB 3KHU), which shows partial disorder of
NAD
+ in only one trimer [28]. Within the dimeric unit (Fig. 4),
residues from both protomers are in contact with each UDP-
glucose in the two active sites [28]. Indeed, Arg260 from one
subunit binds to the glucose moiety in the second subunit while
residues 265–280, which include active site residues Cys276 and
Asp280, surround the UDP-glucose in the first subunit. Hence, the
occupancy of one UDP-glucose binding site will have direct
implications for the occupation and reaction state of the second
Figure 5. Cooperativity within the hUGDH trimeric unit. Here, movement of the protomer A Thr131 loop into the active water-binding site is
associated with an adjustment to the a6-helix, which mediates contact to the next protomer E in the trimeric unit. (A) Portions of protomers A
(green), B (brown) and E (gray surface) from the open hexamer. (B) Close up of Thr131 in the active water-binding site. (C) Portions of protomers A
(teal), B (orange) and E (pink surface) from the closed hexamer. (D) Close up of the active water-binding site. Movie S3 shows a morph between these
two structures.
doi:10.1371/journal.pone.0025226.g005
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residues 260–280 act as a reaction sensor that splits the six
protomers into the two sets of three.
Synchronization of the reaction within a trimeric unit is not
achieved through a direct mechanism, since the protomers do not
contact the UDP-glucose in their trimerically related neighbors.
However, the open hexamer structure suggests a possible
communication route. In the open hexamer protomers, Thr131
and the associated loop has moved into the unoccupied active
water and nicotinamide ring of NAD
+ binding sites, resulting in a
shift of the a6 helix region (Fig. 5). This N-terminal domain motif
contains an intra-trimer subunit contact site for the C-terminal
domain of the next protomer. Hence, the reaction state at one
active site maybe communicated in a clockwise direction to the
adjacent protomer (Fig. 2D). We speculate that this may cause the
intra-subunit flexing of the C-terminal domain relative to the N-
terminal domain [28] within the adjacent protomer, relaying the
information to the substrate-binding site, which lies at the junction
of the three domains (Fig. 2). Such a mechanism provides an
explanation as to why the enzyme operates as a trimer of dimers.
Sequentially, one trimer may provide the scaffolding on which the
other trimer can perform reaction-specific conformational changes
without risk of hexamer disintegration. Hence, we propose that
Thr131 and associated loop acts as a second catalytic sensor, in
this case synchronizing the radially associated subunits.
The residue arrangement at the active site of the open hexamer
is broadly consistent with the catalytic mechanism (Fig. 1),
positioning of the C69 hydroxyl of the UDP-glucose near to
Lys220 and Cys276. However, Asp280, which coordinates the
active water, has turned away from the substrate into a non-
productive conformation where it contacts the mainchain carbonyl
oxygen of Leu221 (Fig. 6C,D and Figure S2). Asp280 is required
to be protonated to adopt this conformation. Furthermore,
Thr131 has moved into the active water site obscuring access to
UDP-glucose from the NAD
+ direction (Figs. 5a and 6a). Covalent
attachment of reaction intermediates has been shown to not be
necessary to lock reaction intermediates in the substrate-binding
site during the exchange of NADH for NAD
+ [38]. As such, we
propose that the movement of the Thr131 loop coupled with
domain-domain movements protect substrate intermediates dur-
ing NADH dissociation.
In the reaction cycle, UGDH initially binds to UDP-glucose
and then sequentially binds, reduces, and releases two NAD
+
molecules before releasing the product, UDP-glucuronic acid
(Fig. 1). Mutation of Thr118 to Ala in hUGDH led to a 8-fold
reduction in kcat, demonstrating non-essential mechanistic
importance of this threonine [28]. The conformation of Thr131
at the active site in the dodecamer may have relevance at two
points in the reaction cycle. Firstly, after the reduction of the first
NAD
+, Thr131 may move to protect the intermediate during
NADH:NAD
+ exchange and allow Asp280 to reorient in order to
lose a proton and subsequently repolarize the active water. This
movement and repolarization would be applicable to either of the
proposed mechanisms (Fig. 1, Ia and Ib). Secondly, the structure
of hUGDH bound to UDP-glucuronic acid (PDB code 2QG4
[28]) contains the ordered active water molecule bound to
Asp280. This water molecule is a prime candidate to become
integrated into UDP-glucuronic acid during the reaction (Figure
S1D), and as such, this structure may be a mimetic of the
substrate-bound form rather than the product-bound form. In
contrast, the open hexamer structure suggests that during the
reduction of the second NAD
+, Thr131 may track this active
water as it incorporates into UDP-glucuronic acid, and in turn
drive NADH dissociation (Fig. 1, III and IV). Interestingly, Egger
and coworkers were not able to crystallize apo-hUGDH,
however, yet were successful in crystallizing the T131A mutant
in the apo form, reinforcing the link between Thr131 and ligand
binding [28]. Hence, we propose that the present structure of
hUGDH represents a trapped intermediate conformation that
provides valuable insight into the reaction mechanism. The
observed conformational plasticity indicates that the inhibitor
UDP-a-D-xylose functions by trapping the hUGDH protomers in
an intermediate reaction state leading to the stalling of the
enzyme and placing strain on the symmetrical hexameric
structure. Further stabilization of this conformation will provide
an attractive strategy for inhibitor drug discovery.
Materials and Methods
Protein production
Recombinant wild-type hUGDH was purified and the activity
verified spectrophotometrically by measuring the reduction of
Figure 6. The UDP-glucose binding site. (A, B) The active site conformations of the open and closed hexamers, respectively. (C, D) The position
and hydrogen-bonding pattern of Asp280 in the open and closed hexamers, respectively. The active water molecule is shown as a black sphere.
Movie S4 shows a morph between these two structures.
doi:10.1371/journal.pone.0025226.g006
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+ in the presence of UDP-glucose [39]. A deletion mutant
was generated that lacked amino acids 488–494, which was also
purified via this protocol [32].
Crystallization and Data Collection
Crystals obtained from the full-length protein only diffracted to
6A ˚. Truncating the protein by seven residues produced diffraction
quality crystals. These crystals were grown by equilibrating the
protein solution (10 mg ml21 in 50 mM Tris-HCl, pH 8.0,
0.5 mM EDTA, 10 mM mercaptoethanol, 5 mM UDP-glucose,
2 mM NAD
+, and 7% (v/v) glycerol) mixed 1:l with the reservoir
solution (0.2 M ammonium sulfate, 0.1 M Na cacodylate, pH 6.5,
and 21% PEG 8000) and incubated over 0.5 ml of reservoir
solution at 295 K. The crystals grew within two days [32]. Mass
spectrometry analysis confirmed that the product (UDP-glucuro-
nic acid) could be detected on incubation of UDP-glucose with
hUGDH under the crystallization conditions in the absence of
PEG 8000 and ammonium sulphate, confirming that the enzyme
was active at the pH of the crystallization condition. Diffraction
data to 2.7 A ˚ resolution were collected at the 4A Macromolecular
Crystallography Wiggler Beamline of the Pohang Accelerator
Laboratory (Pohang, Korea) using the X-ray beam at a single
wavelength (1.1272 A ˚) and 1u oscillations. The data set was
indexed and processed with the CCP4 suite of programs [40].
Data processing statistics and crystal characteristics are reported in
Table S1.
Molecular Replacement and Refinement
Initial attempts to solve the structure by molecular replacement,
using the bacterial structure (PDB code 1DLI) as the search model,
failed [27,32]. Using this model, the solution with the highest
correlation coefficient suggested a tetrameric arrangement. The
structure was subsequently solved using molecular replacement on
the release of the hUGDH hexamer structure (PDB code 2Q3E
[28]) with the program PHASER [41]. The dimeric unit was used
as the search model. The solution, which includes six copies of the
search model, was unambiguous with Z-Score values for rotational
and translational functions of 20.8 and 144.4, respectively. The
Patterson function reveals a significant non-origin peak that is
50.2% of the origin peak, consistent with a pseudo translational
symmetry for the two open hexamers. A Matthews coefficient of
2.98 A ˚3D a 21 can be derived for a dodecamer, this relates to
58.73% solvent content. Refinement was initially was carried out
using an automated protocol with NCS restraints in PHENIX
[42]. Careful model rebuilding subsequent rounds of refinement,
in REFMAC and COOT [43,44], in which the NCS restraints
were released, resulted in the current model (Table S1). The final
model includes ordered residues 1–466. This range matches that
found to be ordered in the structures of full length hUGDH:inhi-
bitor complexes [31] and of the truncated (1–467) hUGDH
complexes [28], which showed normal enzymatic activity. The
coordinates and merged reflection data for hUGDH have been
deposited in the RCSB Protein Data Bank with accession code
3TDK.
Supporting Information
Figure S1 hUGDH ligand binding. 2Fo-Fc OMIT map
electron density contoured at 1 s for (A) the NAD
+ fragments and
(B) UDP-glucose. (C) The conformation of UDP-glucose within
the active site of subunit L. (D) The conformation of UDP-
glucuronic acid (PDB code 2QG4) in the active site. Note: This
structure contains an ordered active water molecule that would
normally become integrated into UDP-glucuronic acid during the
reaction. Hence, the structure may mimic the substrate-bound
form rather than the product-bound form of the enzyme.
(TIF)
Figure S2 The conformation of active site residues. 2Fo-
Fc OMIT map electron density contoured at 1 s around the
active site residues Asn 224, Cys276 and Asp280.
(TIF)
Table S1 Data collection and refinement statistics for
dodecameric hUGDH.
(DOC)
Table S2 Comparison of hUGDH structures. RMS
deviation of Ca positions between hUGDH domains and
protomers. (A) Protomers. (B) N-terminal domains. (C) central
domains. (D) C-terminal domains. (E) Distances between residues
in the N-terminal (Gly166 and Tyr53) and C-terminal (Asp341
and Gly343) domains. Protomers can adopt either an open or a
closed conformation indicated by # and *, respectively. PDB code
2Q3E is a hexamer that represents the reaction start that contains
UDP-glucose and NAD
+ in the ligand binding sites. The 3KHU
hexamer mimics the thiohemiacetal intermediate and contains
UDP-glucose in the NAD
+ binding site. The PDB code 2QG4
hexamer represents the product bound structure with UDP-
glucuronic acid bound at UDP-glucose binding site. This structure
contains NAD
+ in one trimer (subunits B, D, F, H) and a cleaved
version of NAD
+ without the nicotinamide ring in the second
trimer (subunits A, C, E, G) of the dimer-of-trimers that comprise
the hUGDH hexamer, providing structural confirmation of the
three site biological activity. The PDB code 3ITK hexamer
mimics the unbound state of hUGDH in which both ligand-
binding sites do not contain the appropriate ligand. The 3ITK
protomers are in an open conformation with the exception of
subunit F, which is in the closed conformation. F participates in a
dimer interaction with E, the most open of the 3ITK protomers,
suggesting structural cooperativity within the dimeric unit.
(DOC)
Movie S1 Morph between the docecamer and two
copies of the closed hexamer (2Q3E). This morph is only
intended to give an impression of the scale of conformational
change needed to move between these two structures.
(MOV)
Movie S2 Morph between the open hexamer and the
closed hexamer (2Q3E). The pink helix highlights the a6-helix
and the preceding Thr131-containing loop. This morph is only
intended to give an impression of the scale of conformational
change needed to move between these two structures.
(MOV)
Movie S3 Morph between protomers of the open and
the closed (2Q3E) hUGDH hexamers focused at the
active site. The movie shows the flipping of Asp280 (yellow),
movement of Thr131 (pale green) into the active water-binding
site (grey sphere), flipping of Trp214 (lime) and Arg135 (pale
green). This morph is only intended to give an impression of the
scale of conformational change needed to move between these two
structures.
(MOV)
Movie S4 Morph between protomers of the open and
the closed (2Q3E) hUGDH protomers within a trimeric
unit. Here, movement of the Thr131 loop into the active water-
binding site is associated with an adjustment to the a6-helix (all in
yellow), which mediates contact to the next protomer in the
trimeric unit. N-terminal, central and C-terminal domains are
Cooperativity in hUGDH
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intended to give an impression of the scale of conformational
change needed to move between these two structures.
(MOV)
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